As of Feb 16
| +0.67 / +1.13%|
The 18 analysts offering 12-month price forecasts for Abbott Laboratories have a median target of 69.50, with a high estimate of 72.00 and a low estimate of 50.00. The median estimate represents a +15.51% increase from the last price of 60.17.
The current consensus among 23 polled investment analysts is to Buy stock in Abbott Laboratories. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.